TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 26 filers reported holding TENAX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,000 | -41.2% | 58,326 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $17,000 | -63.8% | 58,326 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $47,000 | -23.0% | 58,326 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $61,000 | -40.8% | 58,326 | 0.0% | 0.01% | -40.0% |
Q3 2021 | $103,000 | -18.9% | 58,326 | 0.0% | 0.01% | -16.7% |
Q2 2021 | $127,000 | +14.4% | 58,326 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $111,000 | +2.8% | 58,326 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $108,000 | +20.0% | 58,326 | -0.4% | 0.01% | 0.0% |
Q3 2020 | $90,000 | +69.8% | 58,576 | 0.0% | 0.01% | +50.0% |
Q2 2020 | $53,000 | +60.6% | 58,576 | 0.0% | 0.01% | +33.3% |
Q1 2020 | $33,000 | -60.2% | 58,576 | 0.0% | 0.01% | -57.1% |
Q4 2019 | $83,000 | +18.6% | 58,576 | 0.0% | 0.01% | +7.7% |
Q3 2019 | $70,000 | -13.6% | 58,576 | 0.0% | 0.01% | -13.3% |
Q2 2019 | $81,000 | -31.4% | 58,576 | 0.0% | 0.02% | -34.8% |
Q1 2019 | $118,000 | +66.2% | 58,576 | 0.0% | 0.02% | +43.8% |
Q4 2018 | $71,000 | -76.9% | 58,576 | 0.0% | 0.02% | -77.1% |
Q3 2018 | $308,000 | -16.8% | 58,576 | 0.0% | 0.07% | -29.3% |
Q2 2018 | $370,000 | +15.6% | 58,576 | 0.0% | 0.10% | +7.6% |
Q1 2018 | $320,000 | – | 58,576 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 43,164 | $61,000 | 0.02% |
FAS Wealth Partners, Inc. | 58,576 | $83,000 | 0.01% |
Gradient Investments LLC | 1 | $0 | 0.00% |
Hudock, Inc. | 1 | $0 | 0.00% |
Allworth Financial LP | 1 | $0 | 0.00% |
VANGUARD GROUP INC | 12,200 | $17,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,018 | $7,000 | 0.00% |
UBS Group AG | 72 | $0 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
Advisor Group, Inc. | 3,065 | $4,000 | 0.00% |